Literature DB >> 5316453

Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.

A J Kastin, A V Schally, S Viosca.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5316453     DOI: 10.3181/00379727-137-35805

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

1.  Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y.

Authors:  N Chartrel; J M Conlon; J M Danger; A Fournier; M C Tonon; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

Authors:  A J Kastin; A Barbeau
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

3.  Effect of pimozide on the cytology of the eel pituitary. II. MSH-secreting cells.

Authors:  M Olivereau
Journal:  Cell Tissue Res       Date:  1978-05-29       Impact factor: 5.249

4.  Effects of reserpine administration on the fine structure of the rat pars intermedia.

Authors:  L C Saland
Journal:  Cell Tissue Res       Date:  1978-11-09       Impact factor: 5.249

5.  Effects of pimozide on the ultrastructure of the pars intermedia in the rat.

Authors:  R C Santolaya; D Ciocca
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

6.  MSH-release inhibiting factors: recent studies.

Authors:  A J Kastin; N P Plotnikoff; S Viosca; M S Anderson; A V Schally
Journal:  Yale J Biol Med       Date:  1973-12

7.  Regulation of melanophore stimulating hormone (MSH) release.

Authors:  M E Hadley; A Bower; V J Hruby
Journal:  Yale J Biol Med       Date:  1973-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.